A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia

Clinical trial NCT07011004 · RECRUITING

Trial details

NCT number: NCT07011004
Sponsor: Memorial Sloan Kettering Cancer Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia, in Relapse

Start date: 2025-05-30
Primary completion: 2028-05-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.